Shin Nippon Biomedical Laboratories Ltd is a contract research organization. The Company provides pre-clinical testing services in the pharmaceutical industry.

Consolidated Financial Results For The Six Months Ended September 30, 2025  (Under Japanese Gaap)

Presentation Materials For The First Six Months Of The Fiscal Year Ending March 31, 2026

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Shin Nippon Biomedical Labor (2395 JP)

Consolidated Financial Results For The Six Months Ended September 30, 2025 (Under Japanese Gaap)

Presentation Materials For The First Six Months Of The Fiscal Year Ending March 31, 2026

Notice Regarding Differences Between Consolidated Financial Forecasts And Actual Results For The Six Months Ended September 30, 2025

Notice Regarding Distribution Ofinterim Dividends From Retained Earnings

Consolidated Financial Results For The Three Months Of The Fiscal Year Ending March 31, 2026 (Under Japanese Gaap)

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)